Association Between the Magnitude of Glycemic Control and Body Weight Loss With GLP-1 Receptor Agonists and Risk of Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-analyses of Randomized Diabetes Cardiovascular Outcomes Trials.
Daniel A GomesJoão PresumePedro de Araújo GonçalvesManuel Sousa AlmeidaMiguel MendesJorge FerreiraPublished in: Cardiovascular drugs and therapy (2024)
In T2DM patients, more potent GLP-1 RAs in reducing HbA1c and body weight were associated with greater reductions of MACE.
Keyphrases
- glycemic control
- weight loss
- type diabetes
- cardiovascular disease
- body weight
- blood glucose
- end stage renal disease
- meta analyses
- systematic review
- bariatric surgery
- ejection fraction
- chronic kidney disease
- newly diagnosed
- roux en y gastric bypass
- peritoneal dialysis
- randomized controlled trial
- open label
- gastric bypass
- adipose tissue
- placebo controlled
- coronary artery disease
- study protocol
- patient reported